Travere Therapeutics Inc
Biotechnology
Healthcare
TVTX
88.36 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
25.10
52 week high
27.31
high
25.41
52 week low
0.00
previous Close
25.43
P/E ratio
market cap
1.33 B
div yield
0
net incoming
-41.23 M
31.59 %
net profit margin
-50.44 %
30.00 %
operating incoming
-41.23 M
32.12 %
net change in cash
3.36 M
-84.81 %
cash on hand
61.90 M
5.74 %
cost of revenue
4.68 M
83.27 %
top